Giuseppe Savoja, the medtech giant’s senior business director for Western Europe, posted the announcement on LinkedIn:

“Big news from Medtronic Cardiac Surgery in Europe!” Savoja wrote. “It is with immense excitement that I share a landmark achievement in our journey to advance ECMO patient care: The VitalFlow system is now officially CE marked!”

The VitalFlow extracorporeal membrane oxygenation (ECMO) system provides temporary support for the heart and lungs. It works by circulating a patient’s blood outside the body through a specialized machine. ECMO adds oxygen and removes carbon dioxide, essentially taking over the functions of the heart and lungs.